TOG Review (RCOG Journal)

MRCOG Part 2

Core Surgical Skills

Laparoscopic myomectomy

Key Statistics

  • ~1600/yr — Myomectomies performed in UK
  • 70–80% — Lifetime fibroid incidence (European/African origin)
  • 1 in 500–100 — Age-related leiomyosarcoma risk (<30 to 75–79yr)

Don't-miss facts

  1. No preoperative test definitively excludes leiomyosarcoma – must be stated explicitly during consent for LM/morcellation

  2. Age-related leiomyosarcoma risk (Brohl): 1 in 405 at 40–44yr vs 1 in 216 at 50–54yr; use power morcellation with extreme caution if LM offered >45yr

  3. FDA occult leiomyosarcoma prevalence estimate 1 in 350 (2014) was criticised – recalculated 1 in 1550 (Parker) to 1 in 8300 (Pritts)

  4. Overall LM complications ~11% (major 2%); conversion to open 1%; emergency hysterectomy 0.0–0.3%

  5. Parasitic myomata/DPL after morcellation: incidence 0.1–1%; uncontained morcellation obscures leiomyosarcoma diagnosis in 20% of cases

  6. Vasopressin doses as low as 0.2 units/ml may cause severe cardiopulmonary complications – liaise with anaesthetist

  7. Misoprostol 400 micrograms vaginally preoperatively + intraoperative vasopressin = moderate-quality evidence for reduced blood loss (Cochrane 2014)

  8. In-bag morcellation is still experimental – no proven prognostic benefit for unsuspected malignancy

Evidence/consent essentials

Gold standard: LM for ≤3 symptomatic fibroids, fertility desired

Consent musts: parasitic myomata/DPL, occult malignancy upstaging, no test excludes leiomyosarcoma

Abbreviation Key

  • LM — laparoscopic myomectomy
  • RCOG — Royal College of Obstetricians and Gynaecologists
  • HMB — heavy menstrual bleeding
  • GnRH-a — gonadotrophin-releasing hormone agonist
  • MRI — magnetic resonance imaging
  • DPL — disseminated peritoneal leiomyomatosis
  • UAE — uterine artery embolisation
  • FDA — US Food and Drug Administration
  • MRgFUS — magnetic resonance-guided focused ultrasound
  • AAGL — American Association of Gynecologic Laparoscopists
  • RCT — randomised controlled trial
  • BSGE — British Society for Gynaecological Endoscopy
  • NICE — National Institute for Health and Care Excellence

Source: Bryant-Smith A, Holland T. Laparoscopic myomectomy: a review of alternatives, techniques and controversies. The Obstetrician & Gynaecologist 2018;20:261–268. doi:10.1111/tog.12520

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free